3. Dréno B, Kunstfeld R, Hauschild A, Fosko S, et al. Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomized, regimen-controlled, double-blind, phase 2 trial.… Click to show full abstract
3. Dréno B, Kunstfeld R, Hauschild A, Fosko S, et al. Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomized, regimen-controlled, double-blind, phase 2 trial. Lancet Oncol 2017;18:404–12. 4. Becker LR, Aakhus AE, Reich HC, Lee PK. A novel alternate dosing of vismodegib for treatment of patients with advanced basal cell carcinomas. JAMA Dermatol 2017;153:321–2.
               
Click one of the above tabs to view related content.